IPO · CRGX
CARGO Therapeutics, Inc.
CARGO Therapeutics, Inc. (CRGX) priced its initial public offering on Nov 13, 2023 at $15.00 per share, within its $15.00–$17.00 range, raising $281.2M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $580.1M. Latham & Watkins advised the company and Cooley advised the underwriters.
- Status
- IPO
- Ticker
- CRGX
- Exchange
- Nasdaq Global Select
- Priced
- Nov 13, 2023
- IPO price
- $15.00
- Price range
- $15.00–$17.00
- Raised
- $281.2M
- Market cap at IPO price
- $580.1M
- First filed
- Oct 20, 2023
- Company counsel
- Latham & Watkins
- Underwriters' counsel
- Cooley
- Sector
- Biotech & pharma
- Country / state
- CA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Oct 20, 2023
- Latest amendment Nov 6, 2023
- Final prospectus (424B4) Nov 13, 2023
- All filings on EDGAR CIK 1966494
Other Biotech & pharma IPOs in 2023
- PMGC Holdings Inc.ELAB · Nov 22, 2023 · $6M
- Lexeo Therapeutics, Inc.LXEO · Nov 6, 2023 · $100M
- Abivax S.A.ABVX · Oct 23, 2023 · $235.8M
- Neumora Therapeutics, Inc.NMRA · Sep 18, 2023 · $250.1M
- RayzeBio, Inc.RYZB · Sep 18, 2023 · $311M
- Mira Pharmaceuticals, Inc.MIRA · Aug 4, 2023 · $8.9M